DOCSF 2023: DOCSF Venture Summary

<p>We are delighted to welcome back Nancy Lynch, MD, MBA to our show, where she will be sharing insights on investment and innovation in the MSK (musculoskeletal) space.</p><p>Dr. Lynch highlights that a significant portion of recent investments has been directed towards ortho-facilitated ancillary technologies, with an impressive 75% of these investments being AI-based. She also addresses the impact of the collapse of Silicon Valley Bank on startup financing, emphasizing that it is relatively inconsequential compared to other factors. Venture capitalists are now adopting a more discerning approach to new investments, prioritizing solid business models. Moreover, the prolonged period of uncertainty, global and political issues, market volatility, and the looming possibility of a recession are presenting formidable challenges for startups.</p><p>Tune in to gain valuable insights and recommendations for navigating the potential upcoming period of consolidation and challenges in the world of venture capital.</p>